Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia.

Objectives: Interactions between neuropeptides and psychiatric disorders have been investigated for many years. The aim of this study was to evaluate oxytocin (OXT), arginine-vasopressin (AVP), and atrial natriuretic peptide (ANP) and assess their interactions with each other, as well as investigate these changes with the manifestations of schizophrenia.

Participants And Methods: Thirty-four individuals having acute schizophrenia and 24 healthy individuals as the control group were included in the study.